X4 Pharmaceuticals CEO Paula Ragan's 2021 pay slips 15% to $2.1M
X4 Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 25, 2022
X4 Pharmaceuticals reported fiscal year 2021 executive compensation information on April 25, 2022.
In 2021, three executives at X4 Pharmaceuticals received on average a compensation package of $1.5M, a 6% decrease compared to previous year.
Average pay of disclosed executives at X4 Pharmaceuticals
Paula Ragan, Chief Executive Officer, received $2.1M in total, which decreased by 15% compared to 2020. 59% of Ragan's compensation, or $1.3M, was in stock awards. Ragan also received $309K in non-equity incentive plan, $562K in salary, as well as $12K in other compensation.
Adam S. Mostafa, Chief Financial Officer, received a compensation package of $1.3M, which increased by 14% compared to previous year. 54% of the compensation package, or $724K, was in stock awards.
Derek Meisner, Chief Legal Officer, earned $1M in 2021, a 7% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2022.